No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
REGN241220P710000
- 2.83
- -1.87-39.79%
15min DelayClose Dec 13 16:00 ET
2.83High2.83Low
2.83Open4.70Pre Close3 Volume12 Open Interest710.00Strike Price849.00Turnover40.96%IV3.30%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry2.83Extrinsic Value100Contract SizeAmericanOptions Type-0.2485Delta0.0095Gamma144.10Leverage Ratio-1.1801Theta-0.0220Rho-35.81Eff Leverage0.2591Vega
Intraday
- 5D
- Daily
News
BofA Restarts Coverage of 11 Large-cap Biopharmas
Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,195
Regeneron Pharmaceuticals (REGN): Sales Struggles and Future Prospects
B of A Securities Reinstates Underperform on Regeneron Pharmaceuticals, Announces $565 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Regeneron Presents New And Updated Data For Odronextamab At ASH Annual Meeting